Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
- Sponsored Content
1 Min Read
Sponsored Content
Built on over 30 years of expertise in large-volume fluid processing with 3D single-use bags, Sartorius Stedim Biotech collaborated with many end users for the large-volume Flexsafe® 3D system with enhanced ergonomics, thereby bringing operator safety to the center of successful drug processing.
We conducted in-depth interviews to gather and explore operator insights into the usability of large-volume single-use systems. That input helped us improve our product offering with the aim of also improving workplace health and well being. A focus on ergonomics in single-use operations is a key factor toward achieving easy, fast, and safe liquid handling. A decrease in the appearance of musculoskeletal symptoms in workers can provide a better workplace, with positive effects on worker satisfaction, product quality, and process efficiency.
The large-volume Flexsafe® 3D system is designed specifically for storage of large-volume process fluids up to 3,000 L. Applications include
Storing sterile cell culture media and buffers
Feeding of sterile media into bioreactors and buffers into purification systems
Receiving and storage of bioreactor harvest. Change your day-to-day operations and improve your workplace.
Just fill out the form below to read the full PDF and learn more.
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More